• undefined
      • undefined
    1. Home
    2. People
    3. Lukins, Ed

    Ed Lukins

    Partner

    London

    Ed counsels public and emerging private companies, entrepreneurs, investors and investors on a wide range of capital markets and corporate finance transactions.

    He regularly advises on IPOs, direct listings, follow-ons, de-SPACs, reverse mergers and takeovers on UK, U.S. and European stock exchanges, domestic and cross-border public and private M&A deals, venture capital, private and growth equity investments, debt financings, joint ventures, carve-outs, and restructurings, as well as on governance, disclosure, compliance, and strategic advisory matters.

    His broad industry experience includes working with clients in the AI and technology, healthcare and life sciences, logistics, retail, media, marketing, financial services, energy and natural resources sectors.

    • IPOs / Direct Listings / Follow-ons:

      • AccuStem Sciences Inc. on its Main Market demerger and US OTC listing
      • Ananda Pharma plc on its US OTCQB listing
      • Autolus Therapeutics plc on its Nasdaq IPO
      • B&M European Value Retail S.A. (B&M Stores) on its Main Market IPO
      • capAI plc on Main Market stock loan arrangements
      • Castillo Copper Limited on ASX / Main Market follow-ons
      • Cobra Resources plc on Main Market follow-ons
      • Codex Acquisitions plc on its Main Market SPAC IPO
      • Dispensa Group (formerly Zamaz) plc on its Main Market direct listing and PIPE
      • Endava plc on its NYSE IPO
      • e-Therapeutics plc on its US OTCQX listing
      • GEM (formerly URA) Resources plc on its Main Market IPO
      • Hamak Gold Limited on its Main Market IPO
      • Kistos Holdings plc on its AIM direct listing
      • Mercantile Ports & Logistics Limited on AIM follow-ons
      • National World plc on its Main Market SPAC IPO
      • Nightstar Therapeutics plc on its Nasdaq IPO
      • OKYO Pharma Limited on its Main Market IPO, Nasdaq dual-listing, Main Market de-listing and global follow-ons
      • One Media IP Group plc on AIM follow-ons
      • Panther Metals plc on Main Market follow-ons
      • Realm Therapeutics plc on its direct dual-listing on Nasdaq and subsequent AIM delisting
      • RegTech Open Project plc on its Main Market direct listing
      • Renalytix plc on its demerger, AIM IPO and Nasdaq dual-listing
      • RockRose Energy plc on its Main Market SPAC IPO
      • Scancell Holdings plc on various AIM follow-ons
      • Supply@ME Capital plc on Main Market follow-ons
      • Tiziana Life Sciences Limited on its AIM to Main Market listing step-up, Nasdaq dual-listing, Main Market de-listing and Bermudan re-domiciliation
      • the banks on a Main Market follow-on by Nuformix plc
      • the banks on the Nasdaq IPOs and follow-ons of Bicycle Therapeutics plc, (aborted) Horizon Discovery plc, (aborted) Kymab Limited, (aborted) Mereo BioPharma Group plc, NuCana plc and (aborted) Verona Pharma plc

      Public / Private M&A:

      • Kistos plc on its possible offer for Serica Energy plc
      • Kistos Holdings plc on its acquisition of Mime Petroleum A.S.
      • Mindflair (formerly Pires Investments) plc on its proposed takeover by Tern plc
      • MightyHive Inc. on its acquisition by S4 Capital plc
      • National World plc on its possible offer for Reach plc
      • National World plc on its recommended cash acquisition by Media Concierge (Holdings) Limited
      • National World plc on the auction of The Telegraph Media Group
      • Realm Therapeutics plc on its Nasdaq recommended takeover by Essa Pharma Inc.

      De-SPACs / Reverse Takeovers:

      • Atlas Metals Group plc on its (aborted) Main Market reverse takeover of Compagnie Minière de Oumejrane
      • IGas Energy plc on its AIM reverse takeover of Star Energy Group Limited from PETRONAS International Corporation Limited
      • Kistos plc on its AIM reverse takeover of Tulip
      • National World plc on its Main Market reverse takeover of JPI Media
      • RockRose Energy plc on its Main Market reverse takeovers of certain North Sea interests acquired from Marathon Oil UK and Idemitsu Petroleum
      • Shard Credit Partners Limited (as shareholder) on the AIM reverse takeover by Location Sciences Group plc of Sorted Holdings Limited
      • Technologies New Energy plc on its Main Market de-SPAC of Technologies New Energy S.A.
      • Tooru plc on its AIM reverse takeover of certain operating subsidiaries of S-Ventures plc

      Please note: Ed's experience includes that prior to joining Orrick.

    Insights

    News